Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Asthma | R-HSA-444620 | map05310 | trifluridine | 6256 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | trifluridine | 6256 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | trifluridine | 6256 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | trifluridine | 6256 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | trifluridine | 6256 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | trifluridine | 6256 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | trifluridine | 6256 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | trifluridine | 6256 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | trifluridine | 6256 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | tetracycline | 3960 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | tetracycline | 3960 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | tetracycline | 3960 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | tetracycline | 3960 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | tetracycline | 3960 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | tetracycline | 3960 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | tetracycline | 3960 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | tetracycline | 3960 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | dihydroergotamine | 10531 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | dihydroergotamine | 10531 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | dihydroergotamine | 10531 | drug-path |